Arthur C Madsen, MD | |
175 North 100 West, Ste 205-b, Vernal, UT 84078-2053 | |
(435) 789-6400 | |
(435) 789-6040 |
Full Name | Arthur C Madsen |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 40 Years |
Location | 175 North 100 West, Vernal, Utah |
Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1699745711 | NPI | - | NPPES |
07738 | Medicaid | UT |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 841712341205 (Utah) | Secondary |
207R00000X | Internal Medicine | 171234-1205 (Utah) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Uintah Basin Medical Center | Roosevelt, UT | Hospital |
Ashley Regional Medical Center | Vernal, UT | Hospital |
Mailing Address | Practice Location Address |
---|---|
Arthur C Madsen, MD 175 North 100 West, Ste 205-b, Vernal, UT 84078-2053 Ph: (435) 789-6400 | Arthur C Madsen, MD 175 North 100 West, Ste 205-b, Vernal, UT 84078-2053 Ph: (435) 789-6400 |
News Archive
Researchers at Millennium Pharmaceuticals today announced the discovery of a panel of protein biomarkers that could play a role in the early detection, prognosis and monitoring of rheumatoid arthritis (RA).
Longtime College of Optometry faculty member and University of Houston administrator Earl L. Smith III, O.D., is a member of an elite group of optometrists who has been selected for the prestigious National Optometry Hall of Fame.
Before sharing human research data, scientists routinely strip it of personal information such as name, address, and birthdate in order to protect the privacy of their study participants.
KYTHERA Biopharmaceuticals, Inc., a privately-held biotechnology company focused on the development and commercialization of prescription products in aesthetic medicine, presented results from a long-term follow up study assessing persistence of efficacy and post-treatment safety of ATX-101, a first-in-class, injectable drug that is under investigation for the reduction of submental fat.
It has been suggested for sometime by a range of research studies that lifestyle changes, such as exercising to lose weight and following a healthy diet, are possibly as important as drugs for treating chronic diseases like diabetes, high cholesterol, and hypertension.
› Verified 5 days ago
Sterling Aaron Haws, MD, MPH Internal Medicine Medicare: Medicare Enrolled Practice Location: 150 W 100 N Ste 205c, Vernal, UT 84078 Phone: 435-789-3340 | |
Jon W Hughes, MD PC Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 175 N 100 W, Ste 205-a, Vernal, UT 84078 Phone: 435-789-9272 Fax: 435-789-9222 | |
Kashif Memon, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 175 N 100 W, Suite 205c, Vernal, UT 84078 Phone: 435-789-2433 Fax: 435-789-6892 |